Biomatter Designs Company
Pioneering the technologies for generative protein design at the intersection of synthetic biology and AI.
Technology:
Artificial Intelligence, Biotechnology, Pharmaceutical
Industry:
Early Drug Development
Headquarters:
Vilnius, Vilniaus Apskritis, Lithuania
Founded Date:
2018-01-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
2
Total Funding:
608000
Last Funding Date:
2021-01-11
Last Funding Type:
Seed
Register and Claim Ownership